Cardiff Oncology Inc. Gains 31.61%

Thu, Jun 23, 2022 at 08:30 PM
Cardiff Oncology Inc. Gains 31.61%

Cardiff Oncology Inc. (CRDF:NASDAQ) shot up at $2.29, representing a gain of 31.6%. On Thu, Jun 23, 2022, CRDF:NASDAQ touched a New 2-Week High of $2.29. From Thu, Jun 09, 2022, the stock recorded 33.33% Up Days and 50.00% Green Days

The stock spiked on Thu, Jun 09, 2022 at $2.42 with a volume of 8M+.

About Cardiff Oncology Inc. (CRDF:NASDAQ)

Cardiff Oncology Inc is a clinical-stage, biotechnology company, developing treatment options for cancer patients in indications with the greatest medical need, including KRAS-mutated metastatic...

Share
Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
Your price will remain at $9.99 USD after the discount period
$9.99 USD
monthly
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... or other trends? You're in the right place! Check StockTreats features.